Skip to main content
Leiden University
Scholarly Publications
Home
Submit
About
Select Collection
All collections
Academic speeches
Dissertations
Faculty of Archaeology
Faculty of Governance and Global Affairs
Faculty of Humanities
Faculty of Science
Faculty of Social and Behavioural Sciences
Leiden Journals, Conference Proceedings and Books
Leiden Law School
Leiden University Press
Medicine / Leiden University Medical Centre (LUMC)
Research output UL
Search box
Your Search
Enabled Filters
(-)
= Halkes, S.J.M.
Sort Options
Date (year)
Author / Creator
Title
Refine Results
Resource Type
Article / Letter to editor
(2)
+
-
Availability
Metadata Only
(2)
+
-
Creation Date
2011
(2)
+
-
Faculty
Leiden University Medical Center (LUMC)
(2)
+
-
Collection
Medicine / Leiden University Medical Centre (LUMC)
(2)
+
-
Author
Amadori, S.
(2)
+
-
Halkes, S.J.M.
(2)
+
-
Karrasch, M.
(2)
+
-
Marie, J.P.
(2)
+
-
Meloni, G.
(2)
+
-
Muus, P.
(2)
+
-
Suciu, S.
(2)
+
-
Vignetti, M.
(2)
+
-
Willemze, R.
(2)
+
-
Show more
Language
en
(2)
+
-
Search results
(1 - 2 of 2)
show grid
show list
save search
Willemze, R.; Suciu, S.; Mandelli, F.; Meloni, G.; Labar, B.; Halkes, S.J.M.; ... ; Marie, J.P.
2011
High Dose (HD-AraC) Vs Standard Dose Cytosine Arabinoside (SD-AraC) During Induction and IL-2 Vs Observation After Consolidation/Autologous Stem Cell Transplantation in Patients with Acute Myelogenous Leukemia (AML): Final Report of the AML-12 Trial of EORTC and GIMEMA Leukemia Groups on the Value of High Dose AraC
Article / Letter to editor
metadata only
Willemze, R.; Muus, P.; Halkes, S.J.M.; Meloni, G.; Suciu, S.; Meert, L.; ... ; Marie, J.P.
2011
Clofarabine in Combination with a Standard Remission Induction Regimen (AraC and idarubicin) in Patients with Previously Untreated Intermediate and Bad Risk Acute Myelogenous Leukemia (AML) or High Risk Myelodysplasia (MDS): Phase I Results of An Ongoing Phase I/II Study of the EORTC-LG and GIMEMA(EORTC GIMEMA 06061/AML-14A trial)
Article / Letter to editor
metadata only